William Enright
2021
In 2021, William Enright earned a total compensation of $2.7M as Chief Executive Officer at Barinthus Biotherapeutics plc..
Compensation breakdown
| Non-Equity Incentive Plan | $229,545 |
|---|---|
| Option Awards | $1,984,812 |
| Salary | $474,333 |
| Other | $50,404 |
| Total | $2,739,095 |
Enright received $2M in option awards, accounting for 72% of the total pay in 2021.
Enright also received $229.5K in non-equity incentive plan, $474.3K in salary and $50.4K in other compensation.
Rankings
In 2021, William Enright's compensation ranked 4,788th out of 12,415 executives tracked by ExecPay. In other words, Enright earned more than 61.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,788 out of 12,415 | 61st |
Division Manufacturing | 1,998 out of 5,508 | 64th |
Major group Chemicals And Allied Products | 845 out of 2,378 | 65th |
Industry group Drugs | 757 out of 2,099 | 64th |
Industry Pharmaceutical Preparations | 541 out of 1,549 | 65th |
Source: SEC filing on March 29, 2023.
Enright's colleagues
We found one more compensation record of an executive who worked with William Enright at Barinthus Biotherapeutics plc. in 2021.
2021
Meg Marshall
Barinthus Biotherapeutics plc.